VTRS: Koefisien bali modal nimbang wutah Viatris Inc.

Simbol lan logo merek Mylan (VTRS)

Viatris Inc. (VTRS) reliability in supplying critical medications is constrained by low margins in the generics sector and pressure from Asian manufacturers. The adjusted P/E to growth ratio visualizes these risks, where 0.94 serves as the current parameter value. To stabilize, Viatris Inc. (VTRS) is expanding into emerging markets and complex therapeutic niches, which helps overcome stagnation in mature regions.

VTRS Rasio rega marang bathi tumrap wutah Viatris Inc (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan Viatris Inc. (VTRS)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega Viatris Inc|VTRS - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Nilai pasar Viatris Corp|VTRS - Nilai Total Perusahaan
- indikator kapitalisasi buku:
Nilai Aset Bersih saben Saham Viatris|VTRS - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku viatris.com|VTRS - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Rasio Utang marang Ekuitas Viatris Inc.|VTRS - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal viatris.com|VTRS - Utang perusahaan|Rasio utang marang nilai buku Viatris Corp|VTRS - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Viatris|Likuiditas cepet viatris.com
- data bathi lan kelipatan valuasi:
VTRS - Bathi resik|Prakiraan bathi perusahaan Viatris Inc.|VTRS - Pangali P/E|Pangali Forward P/E Mylan|VTRS - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Viatris Corp|VTRS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Viatris|VTRS - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan viatris.com|VTRS - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Viatris Inc.
Analisis fundamental perusahaan:Viatris Inc (VTRS)
Produk sing diprodhuksi Viatris

To objectively value Viatris Inc. (VTRS), it is necessary to correlate the share price with earnings growth, which allows for the determination of a fair value based on the PEG ratio. This indicator reveals an undervalued asset when the value is below one, reflecting the effectiveness of Scott Smith's portfolio transformation and the pace of debt repayment through the sale of non-core assets to develop high-margin drugs.

Perusahaan pesaing

LLY (Lilly) - Koefisien bali modal nimbang wutah|Pangali PEG ABBV (Abbvie)|Koefisien bali modal nimbang wutah AZN|NVS - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah merck.com|Novo Nordisk (NVO) - Rasio rega marang bathi tumrap wutah|AMGN (Amgen Corp) - Rasio rega marang bathi tumrap wutah|PFE (Pfizer Corporation) - Pangali PEG|Rasio P/E diaturake wutah SNY (Sanofi Group)|Pangali PEG BMY|Kapitalisasi marang bathi resik kanthi nimbang wutah gsk.com|Rasio rega marang bathi tumrap wutah Takeda TAK|TEVA: Rasio P/E diaturake wutah|Dr. Reddy's Lab - Pangali PEG|Rasio rega marang wutah bathi resik Roivant Corp (ROIV)|ZLAB (Zai Lab Limited) - Pangali rega marang bathi tumrap wutah|BHC (bauschhealth.com) - Rasio rega marang bathi tumrap wutah|COSM (Cosmos Health) - Pangali PEG